Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Immunomodulatory Agents and Proteasome Inhibitors in Waldenstrom’s Macroglobulinemia — Steven P. Treon (2016) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Immunomodulatory Agents and Proteasome Inhibitors in Waldenstrom’s Macroglobulinemia
Shared by
Meletios A Dimopoulos
Immunomodulatory Agents and Proteasome Inhibitors in Waldenstrom’s Macroglobulinemia
Chapter In A Book
2016
en
Authors
+1 more
ST
Steven P. Treon
JC
Jorge J. Castillo
EK
Efstathios Kastritis
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2018
Proteasome Inhibitors in Waldenström Macroglobulinemia
Efstathios Kastritis
,
Meletios A Dimopoulos
Article
2013
Proteasome Inhibitor Therapy for Waldenström's Macroglobulinemia
Meletios A Dimopoulos
,
Evangelos Terpos
,
Efstathios Kastritis
Article
2021
Current and novel BTK inhibitors in Waldenström’s macroglobulinemia
Ioannis Ntanasis‐Stathopoulos
,
Maria Gavriatopoulou
,
Despina Fotiou
,
Meletios A Dimopoulos
Article
2023
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia
Eirini Solia
,
Meletios A Dimopoulos
,
Efstathios Kastritis
Article
2022
Managing Waldenström’s macroglobulinemia with BTK inhibitors
Christian Buske
,
Wojciech Jurczak
,
Joe‐Elie Salem
,
Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.